Pulmonary metastasectomy for melanoma

Area of Science:

• Oncology
• Surgical Oncology
• Medical Oncology

Background:

• Malignant melanoma has a high rate of metastasis, with 30% of patients developing secondary disease after primary tumor treatment.
• Metastatic melanoma is typically associated with a poor prognosis and lacks effective chemotherapeutic options.
• Surgical resection of pulmonary metastases from melanoma is a controversial topic due to historically poor survival outcomes.

Purpose of the Study:

• To evaluate the role and outcomes of surgical intervention for pulmonary metastases in patients with malignant melanoma.
• To identify patient subgroups who may benefit from surgical treatment of lung metastases.
• To review existing literature on the surgical management of melanoma pulmonary metastases.

Main Methods:

• Retrospective analysis of 26 patients who underwent surgery for pulmonary metastases between 2000 and 2008.
• Comprehensive literature review of large series reporting on surgical treatment of melanoma lung metastases.
• Evaluation of patient characteristics including performance status, disease-free interval, and tumor biology.

Main Results:

• Surgical treatment remains a viable option for select patients with malignant melanoma and pulmonary metastases.
• Favorable outcomes are associated with good performance status, a long disease-free interval, limited metastatic burden, and less aggressive tumor characteristics.
• The study analyzes the authors' experience alongside a review of extensive published data.

Conclusions:

• Surgical resection of pulmonary metastases can be considered for carefully selected malignant melanoma patients.
• Patient selection is critical for optimizing outcomes in the surgical management of melanoma lung metastases.
• Further research is warranted to refine criteria for surgical candidacy and improve survival.